Acumen Pharmaceuticals, Inc. Increase Decrease In Operating Lease Liability
Acumen Pharmaceuticals, Inc. (ABOS) reported Increase Decrease In Operating Lease Liability of -$80.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2024-11-12
- Acumen Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2024-09-30 was -$30.00K.
- Acumen Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2024-06-30 was -$29.00K.
- Acumen Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2024-03-31 was -$21.00K.
- Acumen Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2023-12-31 was -$7.00K.
- Acumen Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2023 was -$110.00K.
- Acumen Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2022 was -$137.00K.
- Acumen Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2021 was $0.00.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$59.00K derived: sum of 2 quarters · filed 2024-11-12 | -$80.00K 10-Q · filed 2024-11-12 | -$87.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$50.00K 10-Q · filed 2024-08-13 | -$57.00K derived: sum of 3 quarters · filed 2024-08-13 | -$84.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | -$21.00K 10-Q · filed 2024-05-14 | -$28.00K derived: sum of 2 quarters · filed 2024-05-14 | -$55.00K derived: sum of 3 quarters · filed 2024-11-12 | -$93.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$34.00K derived: sum of 2 quarters · filed 2024-11-12 | -$72.00K derived: sum of 3 quarters · filed 2024-11-12 | -$110.00K 10-K · filed 2024-03-26 |
| 2023-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$65.00K derived: sum of 2 quarters · filed 2024-11-12 | -$103.00K 10-Q · filed 2024-11-12 | -$140.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$76.00K 10-Q · filed 2024-08-13 | -$113.00K derived: sum of 3 quarters · filed 2024-08-13 | -$147.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$38.00K 10-Q · filed 2024-05-14 | -$75.00K derived: sum of 2 quarters · filed 2024-05-14 | -$109.00K derived: sum of 3 quarters · filed 2024-05-14 | -$143.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$71.00K derived: sum of 2 quarters · filed 2024-03-26 | -$105.00K derived: sum of 3 quarters · filed 2024-03-26 | -$137.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$68.00K derived: sum of 2 quarters · filed 2023-11-13 | -$100.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$66.00K 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$32.00K 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |